Data / Form D filings / Vesalius Cardiovascular Inc.
Vesalius Cardiovascular Inc.: Form D filings
Vesalius Cardiovascular Inc., a technology company in Vancouver, British Columbia, Canada, filed 5 Form D notices with the SEC between 2022 and 2025. The latest, on August 29, 2025, reports $37,821 sold of a $98,836 offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 200 - 210 WEST BROADWAY, Vancouver, British Columbia, Canada, V5Y 3
- Phone
- (604) 559-6162
- Industry
- Other Technology
- Entity type
- Corporation
- Incorporated in
- Canada (Federal Level)
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1904804
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 29, 2025 | Amendment | $98,836 | $37,821 | $61,015 | 2 | Sep 18, 2023 | sec.gov |
| Aug 22, 2025 | New notice | $50,308 | $50,308 | 1 | Aug 15, 2025 | sec.gov | |
| Sep 17, 2024 | Amendment | $98,836 | $37,821 | $61,015 | 2 | Sep 18, 2023 | sec.gov |
| Sep 22, 2023 | New notice | $98,836 | $37,821 | $61,015 | 2 | Sep 18, 2023 | sec.gov |
| Jan 25, 2022 | New notice | $271,960 | $271,960 | 2 | Dec 20, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Peter Skarsgard | Director, Executive Officer | |
| Vincent Ledoux | Director, Executive Officer |
Every Form D from the week of Aug 25, 2025 · All recent Other Technology filings
Read from SEC EDGAR. Amount sold is what Vesalius Cardiovascular Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.